These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 18214038)

  • 1. Transrectal broadband-Doppler sonography with intravenous contrast medium administration for prostate imaging and biopsy in men with an elevated PSA value and previous negative biopsies.
    Taymoorian K; Thomas A; Slowinski T; Khiabanchian M; Stephan C; Lein M; Deger S; Lenk S; Loening SA; Fischer T
    Anticancer Res; 2007; 27(6C):4315-20. PubMed ID: 18214038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colour Doppler and microbubble contrast agent ultrasonography do not improve cancer detection rate in transrectal systematic prostate biopsy sampling.
    Taverna G; Morandi G; Seveso M; Giusti G; Benetti A; Colombo P; Minuti F; Grizzi F; Graziotti P
    BJU Int; 2011 Dec; 108(11):1723-7. PubMed ID: 21756276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value and limitations of contrast-enhanced transrectal ultrasonography for the detection of prostate cancer.
    Zhao HX; Xia CX; Yin HX; Guo N; Zhu Q
    Eur J Radiol; 2013 Nov; 82(11):e641-7. PubMed ID: 23916578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-enhanced transrectal ultrasonography for the detection of diffuse prostate cancer.
    Gao Y; Liao XH; Lu L; Wang L; Ma Y; Qin HZ; Yan X; Guo P
    Clin Radiol; 2016 Mar; 71(3):258-64. PubMed ID: 26738964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of power doppler and ultrasound contrast agents in early imaging-based diagnosis of organ-confined prostate cancer: Is it possible to spare cores with contrast-guided biopsy?
    Delgado Oliva F; Arlandis Guzman S; Bonillo García M; Broseta Rico E; Boronat Tormo F
    Eur J Radiol; 2016 Oct; 85(10):1778-1785. PubMed ID: 27666616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of contrast-enhanced sonographic micro flow imaging for prostate cancer detection with t-PSA level of 4-10 ng/mL.
    Guo YF; Li FH; Xie SW; Xia JG; Fang H; Li HL
    Eur J Radiol; 2012 Nov; 81(11):3067-71. PubMed ID: 22647421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-time contrast-enhanced transrectal US-guided prostate biopsy: diagnostic accuracy in men with previously negative biopsy results and positive MR imaging findings.
    Cornelis F; Rigou G; Le Bras Y; Coutouly X; Hubrecht R; Yacoub M; Pasticier G; Robert G; Grenier N
    Radiology; 2013 Oct; 269(1):159-66. PubMed ID: 23657887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of transrectal real-time elastography in the diagnosis of prostate cancer.
    Kamoi K; Okihara K; Ochiai A; Ukimura O; Mizutani Y; Kawauchi A; Miki T
    Ultrasound Med Biol; 2008 Jul; 34(7):1025-32. PubMed ID: 18255215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of vardenafil mediated power Doppler ultrasound, contrast enhanced ultrasound and systematic random biopsies to detect prostate cancer.
    Morelli G; Pagni R; Mariani C; Minervini R; Morelli A; Gori F; Ferdeghini EM; Paterni M; Mauro E; Guidi E; Armillotta N; Canale D; Vitti P; Caramella D; Minervini A
    J Urol; 2011 Jun; 185(6):2126-31. PubMed ID: 21496853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of prostate carcinoma with contrast-enhanced sonography using intermittent harmonic imaging.
    Halpern EJ; Ramey JR; Strup SE; Frauscher F; McCue P; Gomella LG
    Cancer; 2005 Dec; 104(11):2373-83. PubMed ID: 16240450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective randomized trial comparing contrast-enhanced targeted versus systematic ultrasound guided biopsies: impact on prostate cancer detection.
    Mitterberger M; Horninger W; Pelzer A; Strasser H; Bartsch G; Moser P; Halpern EJ; Gradl J; Aigner F; Pallwein L; Frauscher F
    Prostate; 2007 Oct; 67(14):1537-42. PubMed ID: 17705242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can Power Doppler enhanced transrectal ultrasound guided biopsy improve prostate cancer detection on first and repeat prostate biopsy?
    Remzi M; Dobrovits M; Reissigl A; Ravery V; Waldert M; Wiunig C; Fong YK; Djavan B;
    Eur Urol; 2004 Oct; 46(4):451-6. PubMed ID: 15363559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of contrast enhanced color Doppler targeted biopsy to conventional systematic biopsy: impact on Gleason score.
    Mitterberger M; Pinggera GM; Horninger W; Bartsch G; Strasser H; Schäfer G; Brunner A; Halpern EJ; Gradl J; Pallwein L; Frauscher F
    J Urol; 2007 Aug; 178(2):464-8; discussion 468. PubMed ID: 17561137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Can indexes based on PSA determine which patients should undergo repeated ultrasound-guided transrectal prostatic biopsy? Study on 546 patients who underwent repeated biopsy].
    Rodríguez-Patrón Rodríguez R; Mayayo Dehesa T; González Galán A; Zuccarino AL; García González R; Cuesta Roca C
    Arch Esp Urol; 2002 Dec; 55(10):225-34. PubMed ID: 12611220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-enhanced ultrasonography using cadence-contrast pulse sequencing technology for targeted biopsy of the prostate.
    Aigner F; Pallwein L; Mitterberger M; Pinggera GM; Mikuz G; Horninger W; Frauscher F
    BJU Int; 2009 Feb; 103(4):458-63. PubMed ID: 19021610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transrectal colour Doppler contrast sonography in the diagnosis of local recurrence after radical prostatectomy--comparison with MRI.
    Drudi FM; Giovagnorio F; Carbone A; Ricci P; Petta S; Cantisani V; Ferrari FS; Marchetti F; Passariello R
    Ultraschall Med; 2006 Apr; 27(2):146-51. PubMed ID: 16602039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [MRI for troubleshooting detection of prostate cancer].
    Beyersdorff D; Hamm B
    Rofo; 2005 Jun; 177(6):788-95. PubMed ID: 15902626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy.
    Sciarra A; Panebianco V; Cattarino S; Busetto GM; De Berardinis E; Ciccariello M; Gentile V; Salciccia S
    BJU Int; 2012 Dec; 110(11):1661-5. PubMed ID: 22564540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of power Doppler ultrasonography for prostate biopsy in men with elevated serum prostate specific antigen levels.
    Ho CC; Khor TW; Singam P; Goh EH; Tan GH; Bahadzor B; Zulkifli MZ
    Clin Ter; 2012; 163(3):211-4. PubMed ID: 22964693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies.
    Anastasiadis AG; Lichy MP; Nagele U; Kuczyk MA; Merseburger AS; Hennenlotter J; Corvin S; Sievert KD; Claussen CD; Stenzl A; Schlemmer HP
    Eur Urol; 2006 Oct; 50(4):738-48; discussion 748-9. PubMed ID: 16630688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.